Cargando…

Evaluation of pembrolizumab for the treatment of advanced non-small cell lung cancer: a retrospective, single-centre, single-arm study

BACKGROUND: Immune checkpoint inhibitors (ICIs) provided a paradigm shift for advanced non-small cell lung cancer (NSCLC) treatment and improved the clinical prognosis of such patients. Pembrolizumab is a humanized anti-programmed death cell protein 1 (PD-1) monoclonal antibody, approved for the tre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Tianxing, Ding, Yun, Chen, Long, Zhu, Lihuan, Lin, Jinlan, Zhang, Jiguang, Huang, Yangyun, Li, Wujin, Lin, Rongjia, Pan, Xiaojie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867846/ https://www.ncbi.nlm.nih.gov/pubmed/33569208 http://dx.doi.org/10.21037/jtd-20-3413

Ejemplares similares

Pembrolizumab combined with paclitaxel and platinum as induction therapy for locally advanced esophageal squamous cell carcinoma: a retrospective, single-center, three-arm study
por: Lin, Wenbao, et al.
Publicado: (2022)

CircMED13L_012 promotes lung adenocarcinoma progression by upregulation of MAPK8 mediated by miR-433-3p
por: Chen, Wenshu, et al.
Publicado: (2021)

TRIM55 suppresses malignant biological behavior of lung adenocarcinoma cells by increasing protein degradation of Snail1
por: Guo, Tianxing, et al.
Publicado: (2022)

Combination of preoperative fibrinogen and neutrophil to lymphocyte ratio is a predictive prognostic factor in ESCC and AEG systematic review
por: Tianxing, Guo, et al.
Publicado: (2019)

miR-452-5p suppressed the metastasis of Non-small cell lung cancer through regulating Moesin
por: Zhuang, Jing, et al.
Publicado: (2023)

LncRNA GAS5 inhibits Invasion and Migration of Lung Cancer through influencing EMT process
por: Zhu, Lihuan, et al.
Publicado: (2021)

Efficacy and safety of pembrolizumab on cervical cancer: A systematic review and single-arm meta-analysis
por: Qi, Lin, et al.
Publicado: (2022)

TRIM9 Interacts with ZEB1 to Suppress Esophageal Cancer by Promoting ZEB1 Protein Degradation via the UPP Pathway
por: Lin, Zhaoxian, et al.
Publicado: (2023)

Correlation Analysis of the TP53 Mutation With Clinical Characteristics in the Prognosis of Non–Small Cell Lung Cancer
por: Zhu, Lihuan, et al.
Publicado: (2023)

Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial
por: Boye, Kjetil, et al.
Publicado: (2021)

CircMMD_007 promotes oncogenic effects in the progression of lung adenocarcinoma through microRNA-197-3p/protein tyrosine phosphatase non-receptor type 9 axis
por: Zhu, Lihuan, et al.
Publicado: (2022)

Brentuximab Vedotin and Pembrolizumab Combination in Patients with Relapsed/Refractory Hodgkin Lymphoma: A Single-Centre Retrospective Analysis
por: Massaro, Fulvio, et al.
Publicado: (2022)

Neoadjuvant Pembrolizumab and Chemotherapy in Resectable Esophageal Cancer: An Open-Label, Single-Arm Study (PEN-ICE)
por: Duan, Hongtao, et al.
Publicado: (2022)

Pembrolizumab Plus Amrubicin in Patients With Relapsed SCLC: Multi-Institutional, Single-Arm Phase 2 Study
por: Akamatsu, Hiroaki, et al.
Publicado: (2021)

Comparison of postoperative cough-related quality of life and recovery between sublobectomy and lobectomy for early-stage non-small cell lung cancer patients: a longitudinal study
por: Lin, Rongjia, et al.
Publicado: (2022)

Prospective, multicentre, single-arm phase II trial of pembrolizumab combined with carboplatin and pemetrexed in elderly patients with advanced, non-squamous non-small cell lung cancer
por: Ozawa, Yuichi, et al.
Publicado: (2020)

TRIM2 directly deubiquitinates and stabilizes Snail1 protein, mediating proliferation and metastasis of lung adenocarcinoma
por: Lin, Zhaoxian, et al.
Publicado: (2020)

Neoadjuvant sintilimab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: a single-arm, single-center, phase 2 trial (ESONICT-1)
por: Zhang, Zhenyang, et al.
Publicado: (2021)

USP2 Inhibits Lung Cancer Pathogenesis by Reducing ARID2 Protein Degradation via Ubiquitination
por: Zhu, Lihuan, et al.
Publicado: (2022)

A single arm phase Ib/II trial of first-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancer
por: Lee, Choong-kun, et al.
Publicado: (2022)

A retrospective analysis of pembrolizumab plus chemotherapy versus pembrolizumab monotherapy for advanced or recurrent non‐small cell lung cancer
por: Isono, Taisuke, et al.
Publicado: (2021)

Robotic-arm assisted partial knee arthroplasty: a single centre experience
por: Marcovigi, Andrea, et al.
Publicado: (2017)

Pembrolizumab Monotherapy for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Arm Phase II Trial (KEYNOTE-629)
por: Grob, Jean-Jacques, et al.
Publicado: (2020)

Pembrolizumab plus azacitidine in patients with chemotherapy refractory metastatic colorectal cancer: a single-arm phase 2 trial and correlative biomarker analysis
por: Kuang, Chaoyuan, et al.
Publicado: (2022)

Open-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell Carcinoma
por: McDermott, David F., et al.
Publicado: (2021)

Effect of roxadustat on red blood cell lifespan in patients with long-term haemodialysis: a single-centre, prospective, single-arm study
por: Zhao, Bing, et al.
Publicado: (2023)

Pembrolizumab-Associated Hypoparathyroidism: A Single Case Report
por: Mahmood, Israa, et al.
Publicado: (2020)

Single-Dose Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy
por: Beudel, Martijn, et al.
Publicado: (2021)

A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone
por: Graff, Julie N, et al.
Publicado: (2020)

A Retrospective Single-Arm Cohort Study in a Single Center of Radiofrequency Ablation in Treatment of Chronic Radiation Proctitis
por: Tang, Chien-En, et al.
Publicado: (2023)

Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma
por: McDermott, David F., et al.
Publicado: (2021)

Ectopic pregnancy in China during 2011–2020: a single-centre retrospective study of 9499 cases
por: Xu, Haihua, et al.
Publicado: (2022)

Construction of Lymph Node Metastasis-Related Prognostic Model and Analysis of Immune Infiltration Mode in Lung Adenocarcinoma
por: Li, Wujin, et al.
Publicado: (2022)

Effectiveness and safety profile of pembrolizumab for metastatic urothelial cancer: A retrospective single‐center analysis in Japan
por: Fujiwara, Motohiro, et al.
Publicado: (2021)

The benefits and risks of pembrolizumab in combination with chemotherapy as first-line therapy in small-cell lung cancer: a single-arm meta-analysis of noncomparative clinical studies and randomized control trials
por: Liu, Qiangyun, et al.
Publicado: (2021)

A phase 1b single-arm trial of intratumoral oncolytic virus V937 in combination with pembrolizumab in patients with advanced melanoma: results from the CAPRA study
por: Silk, Ann W., et al.
Publicado: (2022)

Congenital haemangiomas: a single-centre retrospective review
por: Braun, Victoire, et al.
Publicado: (2020)

Multiple Autoimmune Complications After a Single Dose of Pembrolizumab
por: Ahdi, Hardeep S, et al.
Publicado: (2023)

Pembrolizumab monotherapy versus pembrolizumab plus chemotherapy in patients with non‐small‐cell lung cancer: A multicenter retrospective trial
por: Matsumoto, Hiromi, et al.
Publicado: (2021)

An Advanced Transcriptional Response to Corticosterone After Single Prolonged Stress in Male Rats
por: Ding, Jinlan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dlohvranhf3bem7nsq0j3vsa3n